CONSUMPTION TREND OF OPIOIDS IN AMBULATORY PATIENTS IN ALBANIA 2014-2019
DOI:
https://doi.org/10.22159/ajpcr.2021.v14i11.42988Keywords:
Opioids, Morphine, Consumption, Defined daily doseAbstract
Objective: The aim of this paper is to evaluate 6‐year trends in community use of prescribed opioid analgesics in Albania, using the Anatomic Therapeutic Chemical Classification-Defined Daily Dose methodology.
Methods: We collected the data from the database of the Health Insurance Institute (HII). Analysis of the data includes the period 2014–2019; also, we analyzed the data of import and domestic production of drugs, which represent the real consumption of drugs in the country. These data were subsequently involved in a comparative analysis of the utilization data according to the HII.
Results: We report a 2.5 fold increase in opioid utilization over the study period. The maximal rise in consumption refers to fentanyl, oxycodone, and tramadol. Meanwhile, the maximal values of consumption refer to strong opiate, morphine. We note that around 30% of the consumption of this class flows out of the scheme. Furthermore, around 25% of consumption of morphine and oxycodone flows out of scheme too. Meanwhile, the tramadol consumption runs out of the scheme over 200%.
Conclusions: The outcomes indicate that patients in Albania have low access to opioids medications mainly because of low opioids availability. A strong opiophobia among the population and the medical professionals constitutes one of the major impediments for efficient palliative care.
Downloads
References
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333. DOI: https://doi.org/10.1016/j.ejpain.2005.06.009
International Narcotics Control Board. Estimated World Opioid Requirements for 2018; 2018. Vienna: United Nations Publication. Available from: https://www.incb.org/incb/en/narcotic-drygs/Technical Reports/narcotic drugs reports.html [Last accessed on 2018 Feb 10].
Paulozzi LJ, Mack KA, Hockenberry JM. Vital signs: Variation among states in prescribing of opioid pain relievers and benzodiazepines United States, 2012. MMWR Morb Mortal Wkly Rep 2014;63;563-8. DOI: https://doi.org/10.1016/j.jsr.2014.09.001
Centers for Disease Control and Prevention. 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes United States. Surveillance Special Report 2pdf icon. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Published August 31; 2018.
Banta-Green CJ, Merrill JO, Doyle SR, Boudreau DM, Calsyn DA. Opioid use behaviors, mental health and pain development of a typology of chronic pain patients. Drug Alcohol Depend 2009;104:34-42. DOI: https://doi.org/10.1016/j.drugalcdep.2009.03.021
Boscarino JA, Rukstalis M, Hoffman SN, Han JJ, Erlich PM, Gerhard GS, et al. Risk factors for drug dependence among outpatients on opioid therapy in a large US health-care system. Addiction 2010;105:1776-82. DOI: https://doi.org/10.1111/j.1360-0443.2010.03052.x
Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain 2007;8:573-82. DOI: https://doi.org/10.1016/j.jpain.2007.02.432
Levy B, Paulozzi L, Mack KA, Jones CM. Trends in opioid analgesic prescribing rates by specialty, U.S., 2007-2012. Am J Prev Med 2015;49:409-13. DOI: https://doi.org/10.1016/j.amepre.2015.02.020
Daubresse M, Chang HY, Yu Y, Viswanathan S, Shah ND, Stafford RS, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med Care 2013;51:870-8. DOI: https://doi.org/10.1097/MLR.0b013e3182a95d86
Health Insurance Institute, Tirana, Albania. Available from: http://www. fsdksh.com.al/images/2017/Botime/Raporti_Vjetor_2016/Raporti_ Vjetor_FSDKSH_Anglisht.pdf [Last accessed on 2021 Mar 03].
Institute of Statistics; INSTAT, Tirana, Albania. Available from: http:// www.instat.gov.al/en [Last accessed on 2021 Mar 03].
General Customs Directorate, Ministry of Finance, Tirana, Albania. Available from: http://www.dogana.gov.al/english/c/171/197/199/ general-directorate-of-customs [Last accessed 2021 on Mar 03].
Rapporti OsMed Agenzia Italiana del Farmaco. Available from: https://aifa.gov.it› rapporti-osmed. L’uso dei farmaci in Italia FNOPI; (2009-2019); 2021.
Statistics on Medicines Ravimiamet. Available from: https:// ravimiamet.ee › statistics-medicines. Available from: http://www. ravimiamet.ee/en/statistics-medicines; http://www.ravimiamet. ee›baltijas_statistika_2016-2018 [Last accessed on 2021 Mar 03].
Norwegian Institute of Public Health. Drug Consumption in Norway 2006-2010. Department of Pharmaco-epidemiology, Norwegian Institute of Public Health. Available from: http://www. legemiddelforbruk.no [Last accessed on 2021 Mar 03].
Drug Consumption in Norway 2011-2015. Available from: https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2016/ legemiddelforbruket-i-norge-2011-2015-pdf.pdf [Last accessed on 2021 Mar 03].
Drug Consumption in Norway 2011-2015. Available from: https://www. fhi.no/en/publ/2017/drug-consumption-2012-2016 [Last accessed on 2021 Mar 03].
Suomen lääketilasto 2019, Finnish Statistics on Medicines. Suomen lääketilasto; 2019.
Finnish Statistics on Medicines 2007. National Agency for Medicines, Department of Safety and Drug Information. Available from: https:// www.kela.fi/web/en/statistical-publications_finnish-statistics-on-medicines [Last accessed on 2021 Mar 03].
Finnish Statistics on Medicines 2014. National Agency for Medicines, Department of Safety and Drug Information. Available from: https:// www.kela.fi/web/en/statistical-publications_finnish-statistics-on-medicines [Last accessed on 2021 Mar 03].
Finnish Statistics on Medicines 2016. National Agency for Medicines, Department of Safety and Drug Information. Available from: https:// www.kela.fi/web/en/statistical-publications_finnish-statistics-on-medicines [Last accessed on 2021 Mar 03].
2019: Legemiddelforbruket i Norge 2014-2018. elektronisk utgave: 978-82-8406-011-8 [Last accessed on 2021 Mar 03].
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global burden of disease study 2010. Lancet 2013;380:2163-96. DOI: https://doi.org/10.1016/S0140-6736(12)61729-2
Institute of Medicine. Relieving pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: The National Academies Press; 2011.
International Association for the Study of Pain. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the international association for the study of pain, subcommittee on taxonomy. Pain Suppl 1986;3:S1-226.
Furlan A, Chaparro LE, Irvin E, Mailis-Gagnon A. A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic non-cancer pain. Pain Res Manag 2011;16:337-51. DOI: https://doi.org/10.1155/2011/465281
American Pain Society, American Academy of Pain Medicine Opioids Guidelines Panel. Guideline for the use of chronic opioid therapy in chronic non-cancer pain: Evidence review. Chicago, IL: American Pain Society; 2009. Available from: http://americanpainsociety.org/uploads/ education/guidelines/chronic-opioid-therapy-cncp.pdf
Anastassopoulos KP, Chow W, Tapia CI, Baik R, Moskowitz B, Kim MS. Reported side effects, bother, satisfaction, and adherence in patients taking hydrocodone for non-cancer pain. J Opioid Manag 2013;9:97-109. DOI: https://doi.org/10.5055/jom.2012.0151
Gregorian RS Jr., Gasik A, Kwong WJ, Voeller S, Kavanagh S. Importance of side effects in opioid treatment: A trade-off analysis with patients and physicians. J Pain 2010;11:1095-108. DOI: https://doi.org/10.1016/j.jpain.2010.02.007
Thielke SM, Turner JA, Shortreed SM, Saunders K, Leresche L, Campbell CI, et al. Do patient-perceived pros and cons of opioids predict sustained higher-dose use? Clin J Pain 2014;30:93-101. DOI: https://doi.org/10.1097/AJP.0b013e31828e361b
Chou R, Deyo R, Devine B, Hansen R, Sullivan S, Jarvik JG. The Effectiveness and Risks of Long-term Opioid Treatment of Chronic Pain. Evidence Report/Technology Assessment No. 218. AHRQ Publication No. 14-E005-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014. Available from: http://www. effectivehealthcare. ahrq.gov/ehc/products/557/1971/chronic-painopioid-treatment-report-141007.pdf
Centers for Disease Control and Prevention. National Center for Health Statistics. Health, United States, 2014: With special feature on adults aged 55-64. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics. Atlanta, Georgia: Centers for Disease Control and Prevention; 2015.
Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long‐term opioid therapy for chronic pain: A systematic review for a National Institutes of Health pathway to prevention workshop. Ann Intern Med 2015;162:276-86. DOI: https://doi.org/10.7326/M14-2559
Breivik H. Opioids in chronic non‐cancer pain, indications and controversies. Eur J Pain 2005;9:127-30. DOI: https://doi.org/10.1016/j.ejpain.2004.05.013
Rama R, Çarçani V, Prifti F, Huta K, Xhixha A, Connor SR. Palliative care-Albania. J Pain Symptom Manag 2018;55:S14-8. DOI: https://doi.org/10.1016/j.jpainsymman.2017.05.014
Opioid use/Health at e Glance 2019: OECD Indicators. Available from: https://www.oecd-ilibrary.org
Fischer B, Jones W, Rehm J. Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: An update with a focus on recent interventions. BMC Health Serv Res 2014;14:90. DOI: https://doi.org/10.1186/1472-6963-14-90
Hamunen K, Paakkari P, Kalso E. Trends in opioid consumption in the Nordic countries 2002-2006. Eur J Pain 2009;13:954-62. DOI: https://doi.org/10.1016/j.ejpain.2008.11.006
US Food and Drug Administration. FDA Announces Safety Labeling Changes and Post Market Study Requirements for Extended‐release and Long‐acting Opioid Analgesics. Press Release; 2013. Available from:http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm367726.htm [Last accessed on 2015 Sep 16].
Furlan AD, Sandoval JA, Mailis‐Gagnon A, Tunks E. Opioids for chronic noncancer pain: A meta‐analysis of effectiveness and side effects. Can Med Assoc J 2006;174:1589-94. DOI: https://doi.org/10.1503/cmaj.051528
Przewłocki R, Przewłocka B. Opioids in chronic pain. Eur J Pharmacol 2001;429:79-91. DOI: https://doi.org/10.1016/S0014-2999(01)01308-5
Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: A review of the evidence. Clin J Pain 2008;24:469-78. DOI: https://doi.org/10.1097/AJP.0b013e31816b2f26
Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long‐term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010;1:CD006605. DOI: https://doi.org/10.1002/14651858.CD006605.pub2
Chaparro LE, Furlan AD, Deshpande A, Mailis‐Gagnon A, Atlas S, Turk DC. Opioids compared to placebo or other treatments for chronic low‐back pain. Cochrane Database Syst Rev 2013;8:CD004959. DOI: https://doi.org/10.1002/14651858.CD004959.pub4
Campbell CI, Weisner C, LeResche L, Ray GT, Saunders K, Sullivan MD, et al. Age and gender trends in long‐term opioid analgesic use for noncancer pain. Am J Public Health 2010;100:2541-7. DOI: https://doi.org/10.2105/AJPH.2009.180646
Melnikova I. Pain market. Nat Rev Drug Discov 2010;9:589-90. DOI: https://doi.org/10.1038/nrd3226
Makris UE, Abrams RC, Gurland B, Reid MC. Management of persistent pain in the older patient: A clinical review. JAMA 2014;312:825-37. DOI: https://doi.org/10.1001/jama.2014.9405
Atluri S, Sudarshan G, Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician 2014;17:e119-28. DOI: https://doi.org/10.36076/ppj.2014/17/E119
Buntin-Mushock C, Phillip L, Moriyama K, Palmer PP. Age-dependent opioid escalation in chronic pain patients. Anesth Analg 2005;100:1740-5. DOI: https://doi.org/10.1213/01.ANE.0000152191.29311.9B
Published
How to Cite
Issue
Section
Copyright (c) 2021 LAERTA KAKARIQI, SOKRAT XHAXHO, LEONARD DEDA, GENTIAN VYSHKA
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
